
|Articles|October 28, 2021
Pharmacy Clinical Pearl of the Day: Colon Cancer
Author(s)Saro Arakelians, PharmD
Chemotherapy for colorectal cancer include 5-fluorouracil (5-FU), capecitabine (Xeloda), irinotecan (Camptosar), oxaliplatin (Eloxatin), and trifluridine and tipiracil (Lonsurf).
Advertisement
Clinical Pearl of the Day: Colon Cancer
Colon cancer is a type of cancer that begins in the large intestine (colon).
Insight:
- Colon cancer typically affects older adults, though it can happen at any age.
- Symptoms may include change in bowel habits, diarrhea, constipation, rectal bleeding, persistent abdominal discomfort, weakness or fatigue, and unexplained weight loss.
- Risk factors include older age, African American race, history of colorectal cancer, inflammatory intestinal conditions, obesity, diabetes, smoking, alcohol use, and family history.
- Treatment includes polypectomy, mucosal resection, partial colectomy, lymph nodes removal, chemotherapy, radiation therapy, targeted drug therapy, immunotherapy, and palliative care.
- Some drugs used as chemotherapy for colorectal cancer include 5-fluorouracil (5-FU), capecitabine (Xeloda), irinotecan (Camptosar), oxaliplatin (Eloxatin), and trifluridine and tipiracil (Lonsurf).
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
KEYNOTE Trial Data Presented at ESMO 2025 Congress Reiterate Pembrolizumab’s Benefits in NSCLC
3
Court Ruling Highlights Risks of Improper Dose Adjustments
4
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
5















































































































































































































